BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Candesartan Cilexetil

a prodrug which is metabolized to an active form candesartan to exert its biological effects

300+ PubMed studies analyzed · 80 RCTs · Evidence Score: 53.9

Research Domains

Candesartan Cilexetil has been studied across 15 research domains including ❤️ Cardiovascular, 🫘 Kidney, 🔥 Metabolic, 🫁 Liver & Detox, 🦴 Bone & Joint. The primary research focus is ❤️ Cardiovascular with 58% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Candesartan Cilexetil, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Gestrinone
18 shared targets
Cetylpyridinium
17 shared targets
Spironolactone
17 shared targets
Ethoxyquin
17 shared targets
Norethindrone
16 shared targets
Flutamide
20 shared targets
Troglitazone
25 shared targets
Loratadine
22 shared targets
Simvastatin
21 shared targets
Polidocanol
16 shared targets
Loading evidence profile...

This evidence profile for Candesartan Cilexetil is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.